Zhejiang Jianfeng Group announced that its wholly-owned subsidiary, Jianfeng Pharmaceutical's controlling subsidiary, Er Ying Company, received the approval notice for the supplementary application of acetaminophen suppository in 75mg specification issued by the National Medical Products Administration. Acetaminophen suppository is an antipyretic and analgesic pharmaceutical used for fevers caused by common colds or influenza in children and also used to relieve mild to moderate pain.
尖峰集团：子公司获得乙酰氨基酚栓补充申请批准
Zhejiang Jianfeng Group: Subsidiary receives approval for acetaminophen suppository supplementary application.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated